The ether lipid analogue l-octadecyl-2-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3) has been recently shown to induce apoptosis in the human leukaemic 
INTRODUCTION
Synthetic ether phospholipids seem to constitute a novel class of anti-tumour agents [1] . The ether lipid 1-octadecyl-2-methyl-racglycero-3-phosphocholine (ET-1 8-OCH3) is a synthetic analogue of 2-lysophosphatidylcholine and acts as an strong anti-tumour agent [2] [3] [4] . It has been recently reported that the ether lipid ET-18-OCH3 promotes apoptosis in human myeloid leukaemic cells [5, 6] . The precise mechanism involved in the ET-18-OCH3 effect on apoptosis remains to be established, even though a number of biochemical processes have been described as being induced by alkyl phospholipids analogues, such as disturbance of phospholipid metabolism of the plasma membrane [7, 8] , inhibition of cellular transport systems [9] , and modification of Ptdlns phospholipase C and protein kinase C activities [10] [11] [12] .
It has been suggested that expression of the proto-oncogenes c-fos and c-jun plays an active role in the onset of programmed cell death in lymphoid cells [13] . The nuclear proto-oncogenes cfos and c-jun encode two components of the transcription factor AP-1 [14] , which binds to the palindromic consensus sequence 5'-TGA(G/C)TCA-3', known as the AP-1 site, and affects the transcriptional control of AP-1 responsive genes [14] . Two other c-jun-related genes, jun B and jun D, encode proteins that show extensive amino acid identity with c-Jun [15, 16] . Dimer formation between Fos/Jun or Jun/Jun proto-oncogenes is a prerequisite to constitute a functional active AP-1 complex [14] . In this study, we Northern blot analysis Total RNA was isolated by the guanidine thiocynate/CsCl method [18] . Samples of 20 ,ug of RNA were electrophoresed on 0.9 % (w/v) agarose-formaldehyde gels, and then transferred to nitrocellulose membranes (Schleicher und Schuell, Dassel, Germany) as previously described [19] . 32P-labelled cDNA probes were prepared using the random hexanucleotide priming method [20] (Oligo-Labelling Kit, Pharmacia, Uppsala, Sweden) to a specific radioactivity > 7 x 101 c.p.m.//tg of cDNA. cDNA probes for c-fos [21] , c-jun [22] , jun B [15] and jun D [16] were kindly provided by Dr. P. Sassone-Corsi (Laboratoire de Genetique Moleculaire des Eucaryotes, Centre National de la Recherche Scientifique, Strasbourg, France) and Dr. R. Bravo (Squibb Institute, Princeton, NJ, U.S.A.). Under the experimental conditions used in the Northern blot analysis, there was no cross-reactivity among the above probes [23] . Conditions for blot hybridization and washing have been described elsewhere [19] .
Gel retardation analysis
Mini-nuclear extracts were obtained from -3 x 106 cells as previously described [19] , and aliquots (4 jug) from each nuclear extract were used in each binding assay. The assays were performed as described [19] , using a synthethic 22 bp oligonucleotide containing the AP-1 consensus sequence 5'-CTAGTGATGAGTCAGCCGGATC-3'. Inhibition of complex formation with anti-(Fos M) peptide antiserum was performed as described [19] .
Electroporatlon and CAT assays Jurkat cells (20 x 
RESULTS AND DISCUSSION
We have previously found that low doses of ET-I 8-OCH3 (3 ,tg/ml) induce apoptosis in the human myeloid leukaemic HL-60 cells (promyelocytic) and U937 cells (promonocytic) [5] . We have also found that this ether lipid promotes programmed cell death in the human T The three human leukaemic cell lines HL-60, U937 and Jurkat were able to accumulate a significant amount of ET-18-OCH3 (Figure 1 ). After 6 h treatment with 3 ,tg/ml ET-18-OCH3, when the ether-lipid-induced apoptosis in the three human leukaemic cell lines was clearly observed by DNA degradation into oligonucleosome-size fragments (results not shown) [5] , HL-60, U937 and Jurkat cells incorporated 732 + 138, 663 + 146 and 329+14ng of ET-18-OCH3/106cells respectively (Figure 1 ). However, human peripheral blood lymphocytes (PBLs) did not incorporate this ether lipid (Figure 1 ), and these cells were not susceptible to undergoing apoptosis upon ET-18-OCH3 treatment (F. Mollinedo, R. Martinez-Dalmau, C. Gajate and M. Modolell, unpublished work). Thus, uptake of this ether lipid into the cell seems to be required for ET-18-OCH3-induced programmed cell death.
A role for c-fos and c-jun, components ofthe AP-1 transcription factor, in the induction of apoptosis has been recently suggested [13] . Thus, we have examined the effect of ET-18-OCH3 on the expression of c-fos and of the three members of the jun family proto-oncogenes in human myeloid and lymphoid leukaemic cells. Addition of ET-18-OCH3 to promyelocytic HL-60 cells induced an increase in the 2.2 kb c-fos, 2.7 kb c-jun, 2.1 kbjun B and 2.0 kb jun D steady-state mRNA levels (Figure 2 ). After overexposure of the autoradiograms corresponding to c-jun, an additional minor band of 3.4 kb, suggested to be a precursor molecule [26] , was also evident. Similar results were obtained with U937 cells (Figure 3) . A remarkable c-jun mRNA induction was achieved within 2 and 4 h of ET-18-OCH3 treatment in HL-60 and U937 cells respectively (Figures 2 and 3) , and a sustained and high accumulation of jun D transcripts was observed in both HL-60 and U937 cells upon ET-18-OCH3 treatment (Figures 2  and 3 ). On the other hand, the addition of ET-18-OCH3 to the human T lymphoid Jurkat cells induced a remarkable increase in the steady-state mRNA levels of c-jun andjun B proto-oncogenes ( Figure 3 ). An Furthermore, addition of ET-1 8-OCH3 to U937 or HL-60 cells induced an enhancement of DNA-binding activity of the transcription factor AP-1 to its cognate sequence in both cell types (Figure 4 ). We confirmed with specific anti-(Fos M) antibody that the DNA-binding complex required the presence of Fos protein ( Figure 4c) .
As treatment of Jurkat T cells with ET-1 8-OCH3 produced an increase in the steady-state mRNA levels of components of the transcription factor AP-1, we examined the effect of ET-18-OCH3 on the functional activation of the AP-l transcription factor. Thus, we electroporated into Jurkat cells the AP-l-TK-CAT plasmid [24] , which contains a single copy of the AP-1 site inserted upstream of position -109 of the herpes simplex virus thymidine kinase promoter and fused to the structural gene coding for CAT gene, used as reporter gene. The addition of 4,f-phorbol 12-myristate 13-acetate (PMA) to these cells stimulated CAT activity from the construct containing an AP-1 site (Table 1) , but not the activity of the plasmid TK-CAT lacking the AP-1 enhancer element (Table 1) . Interestingly, addition of ET-18-OCH3 (3 ,ug/ml) to Jurkat cells electroporated with the AP-l-TK-CAT construct induced a 16.3-fold increase in CAT activity (Table 1) . This effect was dose-dependent, with 2 ,tg/ml ET-18-OCH3 being the threshold concentration to yield a measurable effect on AP-1 enhancer activity. This ET-18-OCH3 dose is within the concentration range of the ether lipid required to induce apoptosis of human leukaemic cells [5] . ET-1 8-OCH3 had no effect on the CAT activity of the construct lacking the AP-l enhancer element (Table 1) .
The data reported herein demonstrate for the first time that the ether lipid ET-18-OCH3 is able to induce expression offos and jun proto-oncogenes and to activate the transcription factor AP-l in human leukaemic cells. In this context, it has been very recently reported that ET-18-OCH3 stimulates the expression of c-fos in rat primary astroglial cell cultures [27] . Previous reports suggested that ether lipids, including ET-18-OCH3, exert their destructive actions on tumour cells by interfering with the cell membrane phospholipid metabolism or with other processes occurring in the cell membrane, but not by affecting nuclear processes [1, 2] [1] . In this regard, it has been reported that ET-18-OCH3 activates macrophages which acquire cytotoxicity against tumour cells [1, 2] . As the transcription factor AP-I regulates the expression of several cytokines and proteins that play a key role in macrophage function, it could be suggested that the enhancement of the tumouricidal activity of macrophages after incubation with ET-18-OCH3 might be, at least in part, mediated by the action of this ether lipid on the activity of transcription factor AP-1.
